Cover [Abstract]
Entity Registrant Name
Entity Central Index Key
Document Type
Amendment Flag
Current Fiscal Year End Date
Entity Small Business
Entity Shell Company
Entity Emerging Growth Company
Entity Current Reporting Status
Document Period End Date
Entity Filer Category
Document Fiscal Period Focus
Document Fiscal Year Focus
Entity Common Stock Shares Outstanding
Document Quarterly Report
Document Transition Report
Entity File Number
Entity Incorporation State Country Code
Entity Tax Identification Number
Entity Address Address Line 1
Entity Address Address Line 2
Entity Address City Or Town
Entity Address State Or Province
Entity Address Postal Zip Code
City Area Code
Local Phone Number
Security 12b Title
Trading Symbol
Security Exchange Name
Entity Interactive Data Current
Condensed Consolidated Balance Sheets
Current Assets
Cash and cash equivalents
Accounts receivable
Prepaid expenses
Other current assets
Total Current Assets
[Assets, Current]
Property and equipment, net
Operating lease right-of-use assets
Intangible assets, net
Total Assets
[Assets]
Current Liabilities
Accounts payable
Accrued liabilities
Deferred revenue
Management and directors' fees payable
Current portion of long-term debt
Current portion of finance lease liabilities
Current portion of operating lease liabilities
Current portion of grant repayable
Warrant liability
Derivative liability
Current portion of convertible note payable, net
Total Current Liabilities
[Liabilities, Current]
Long-term debt, net of current portion
Deferred revenue, net of current portion
Finance lease liabilities, net of current portion
Operating lease liabilities, net of current portion
Grant repayable, net of current portion
Convertible note payable, net of current portion
Total Long-Term Liabilities
[Liabilities, Noncurrent]
Total Liabilities
[Liabilities]
Stockholders' Deficit
Common Stock Authorized: 325,000,000 shares of common stock, at $0.001 par value per share Issued and outstanding: 12,044,339 shares and 6,288,988 shares, respectively
Additional paid-in capital
Accumulated other comprehensive income
Accumulated deficit
Total VolitionRx limited Stockholders' Deficit
[Equity, Attributable to Parent]
Non-controlling interest
Total Stockholders' Deficit
[Equity, Including Portion Attributable to Noncontrolling Interest]
Total Liabilities and Stockholders' Deficit
[Liabilities and Equity]
Common stock, shares par value
Common stock, shares authorized
Common stock, shares issued
Common stock, shares outstanding
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited)
Revenues
Services
Product
Total Revenues
[Revenues]
Operating Expenses
Research and development
General and administrative
Sales and marketing
Total Operating Expenses
[Operating Expenses]
Operating Loss
[Operating Income (Loss)]
Other Income (Expenses)
Grant income (loss)
Gain on disposal of fixed assets
Interest income
Interest expense
[Interest Expense, Nonoperating]
Amortization of debt discount
[Amortization of Debt Discount (Premium)]
Gain (loss) on change in fair value of derivative liability
Gain (loss) on change in fair value of warrant liability
Loss on extinguishment of debt
Total Other Income (Expenses)
[Other Nonoperating Income (Expense)]
Net Loss
[Net Income (Loss), Including Portion Attributable to Noncontrolling Interest]
Net Loss Attributable to Non-Controlling Interest
[Net Income (Loss) Attributable to Noncontrolling Interest]
Net Loss Attributable to VolitionRx Limited Stockholders
[Net Income (Loss) Attributable to Parent]
Other Comprehensive Income (Loss)
Foreign currency translation adjustments
Net Comprehensive Loss
Net Loss Attributable to VolitionRx Limited Stockholders
[Net Income (Loss) Allocated to Limited Partners]
Deemed dividend - down round provision in warrants
Net Loss Attributable to Common Stockholders
[Net Income (Loss) Available to Common Stockholders, Diluted]
Net Loss Per Share - Basic and Diluted Attributable to VolitionRx Limited
Weighted Average Shares Outstanding - Basic and Diluted
Condensed Consolidated Statements of Stockholders Deficit (Unaudited)
Statement [Table]
Statement [Line Items]
Equity Components [Axis]
Common stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Non-Controlling Interest
Balance, shares
[Shares, Issued]
Balance, amount
Common stock issued for cash, net of issuance costs, shares
Common stock issued for cash, net of issuance costs, amount
Common stock issued for settlement of RSUs, shares
Common stock issued for settlement of RSUs, amount
Stock-based compensation
Stock-based compensation in relation to modification of options
Tax withholdings paid related to stock-based compensation
Foreign currency translation
Net loss for the period
Common stock issued for cash, in respect of warrant shares, shares
Common stock issued for cash, in respect of warrant shares, amount
Issuance of warrants in connection with convertible note offering
Fair value of convertible note settlement
Common stock issued for settlement of convertible note repayments, shares
Common stock issued for settlement of convertible note repayments, amount
Deemed dividend - down round provision in warrants
[Deemed dividend - down round provision in warrants]
Balance, shares
Balance, amount
Condensed Consolidated Statements of Cash Flows (Unaudited)
Operating Activities
Net loss
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization
Amortization of operating lease right-of-use assets
(Gain) loss on disposal of fixed assets
Amortization of debt discount
Stock-based compensation
[Share-Based Payment Arrangement, Noncash Expense]
Loss on extinguishment of debt
(Gain) loss on change in warrant liability
[(Gain) loss on change in warrant liability]
Loss (gain) on change in fair value of derivative liability
[Loss (gain) on change in fair value of derivative liability]
Mandatory default amount on convertible notes payable
[Mandatory default amount on convertible notes payable]
Changes in operating assets and liabilities:
Prepaid expenses
[Increase (Decrease) in Prepaid Expense]
Accounts receivable
[Increase (Decrease) in Accounts Receivable]
Other current assets
[Increase (Decrease) in Other Current Assets]
Deferred revenue, current and non-current
Accounts payable and accrued liabilities
Management and directors' fees payable
[Increase (Decrease) in Management Fee Payable]
Right-of-use assets operating leases liabilities
Net Cash Used In Operating Activities
[Cash Provided by (Used in) Operating Activity, Including Discontinued Operation]
Investing Activities
Purchases of property and equipment
[Payments to Acquire Property, Plant, and Equipment]
Net Cash Used In Investing Activities
[Cash Provided by (Used in) Investing Activity, Including Discontinued Operation]
Financing Activities
Net proceeds from issuances of common shares
Tax withholdings paid related to stock-based compensation
[Payment, Tax Withholding, Share-Based Payment Arrangement]
Proceeds from grants repayable
Net proceeds from issuances of convertible note and warrants
Proceeds from long-term debt
Payments on long-term debt
[Repayments of Long-Term Debt]
Payments on grants repayable
[Payments on grants repayable]
Payments on convertible loan note
[Repayments of Notes Payable]
Payments on finance lease obligations
[Repayments of Debt and Lease Obligation]
Net Cash Provided By Financing Activities
[Cash Provided by (Used in) Financing Activity, Including Discontinued Operation]
Effect of foreign exchange on cash
Net change in cash and cash equivalents
[Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation]
Cash and cash equivalents - Beginning of the Period
Cash and cash equivalents - End of the Period
Supplemental Disclosures of Cash Flow Information
Interest paid
Non-Cash Financing Activities
Deemed dividend - down round provision in warrants
[Deemed dividend - down round provision in warrants 1]
Common stock issued upon settlement of vested RSUs
Fair value of derivative liability recognized upon issuance of convertible note
Issuance of warrants in connection with convertible note offering
[Issuance of warrants in connection with convertible note offering]
Debt issuance costs recognized upon issuance of convertible note
Common stock issued for settlement of convertible loan note repayments
Offering costs from issuance of common stock
Non-cash note payable
Insider Trading Arrangement [Line Items]
Rule 10b5-1 Arrangement Adopted [Flag]
Rule 10b5-1 Arrangement Terminated [Flag]
Non Rule 10b5-1 Arrangement Adopted [Flag]
Non Rule 10b5-1 Arrangement Terminated [Flag]
Trading Arrangement, Individual Name
Material Terms of Trading Arrangement [Text Block]
Basis of Presentation and Summary of Significant Accounting Policies
Basis of Presentation and Summary of Significant Accounting Policies
Basis of Presentation and Significant Accounting Policies [Text Block]
Liquidity and Going Concern Assessment
Liquidity and Going Concern Assessment
Substantial Doubt about Going Concern [Text Block]
Property and Equipment
Property and Equipment
Property, Plant and Equipment Disclosure [Text Block]
Intangible Assets
Intangible Assets
Intangible Assets Disclosure [Text Block]
Related Party Transactions
Related Party Transactions
Related Party Transactions Disclosure [Text Block]
Common Stock
Common Stock
Equity [Text Block]
Stock-Based Compensation
Stock-based Compensation
Commitments and Contingencies
Commitments and Contingencies
Commitments and Contingencies Disclosure [Text Block]
Subsequent Events
Subsequent Events
Subsequent Events [Text Block]
Basis of Presentation and use of estimates
Recently Issued Accounting Pronouncements
Warrant Liability
Derivative Liability
Fair Value Measurements
Basic and Diluted Net Loss Per Share
Reverse stock split
Schedule Of assets and liabilities measured at fair value on a recurring basis
Schedule of warrant liability measured at fair value
Schedule of derivative liability measured at fair value
Schedule of property and equipment
Schedule of intangible assets
Schedule of annual estimated amortization
Schedule of stock options
Summary of RSUs vested and settled during period
Summary of warrants outstanding
Schedule of changes in series A and series B warrants outstanding
Schedule of warrants issued and outstanding
Schedule of changes in options outstanding
Schedule of options issued and outstanding
Summary of options forfeited, 2015 plan
Summary of RSUs issued and outstanding, 2015 plan
Schedule of RSUs issued and outstanding with contractual life, 2015 plan
Schedule of RSUs vested, 2015 plan
Schedule of RSUs cancelled, 2015 plan
Schedule of RSUs issued and outstanding, 2024 plan
Schedule of RSUs issued and outstanding with contractual life, 2024 plan
Schedule of the RSUs grants, plan 2024
Schedule of the RSUs vested, plan 2024
Schedule of the RSUs cancelled, plan 2024
Schedule of future minimum lease payments under financing leases
Schedule of operating lease right-of-use assets
Schedule of future minimum lease payments under operating leases
Schedule of short-term lease costs due
Schedule of grants repayable
Schedule of long-term debt payable
Schedule of annual payments of collaborative agreement obligations
Schedule of future principal payments of convertible notes payable
Schedule of commitments in respect of corporate goals and performance based awards
Schedule of outcomes related to the prescribed performance targets on the outstanding awards
Fair Value Hierarchy and NAV [Axis]
Award Date [Axis]
Fair Value Inputs Level 2 [Member]
Fair Value Inputs Level 1 [Member]
Fair Value Inputs Level 3 [Member]
May 2025 [Member]
January 2026 [Member]
Warrant liability
[Warrant liability]
Derivative liability
[Derivative Liability]
May 2025 [Member]
January 2026 [Member]
Warrant liability, beginning balance
Gain on change in fair value of warrant liability
Warrant liability, ending balance
Derivative liability beginning balance
Initial fair value of embedded derivative liability upon issuance of convertible note
Gain on change in fair value of derivative liability
Conversion extinguishment
[Extinguishment of Debt, Amount]
Derivative liability ending balance
Warrant liability
Derivative Liability
Potentially dilutive securities excluded from the computation of EPS
Net loss
[Net Income (Loss) Available to Common Stockholders, Basic]
Cash flows in operating activities
Cash and cash equivalents
[Cash and Cash Equivalent]
Accumulated deficit
[Cumulative Earnings (Deficit)]
Stockholders' deficit
Current liabilities
Net proceeds from sales of common stock
Property Plant And Equipment By Type Axis
Product Or Service Axis
Plan Name [Axis]
Computer Hardware And Software [Member]
Laboratory Equipment [Member]
Office Furniture and Equipment [Member]
Buildings [Member]
Building Improvements [Member]
Land [Member]
Bottom [Member]
Top [Member]
Total property and equipment
Less accumulated depreciation
Total property and equipment, net
Useful Life
Depreciation expense
Finite Lived Intangible Assets By Major Class Axis
Patents and Licenses [Member]
Patents and Licenses
Total Patents and Licenses
Less accumulated amortization
Total Patents and Licenses, net
2026 - Remaining
2027
2028
2029
2030
Greater than 5 years
Total Intangible Assets
Indefinite-Lived Intangible Assets [Axis]
Minimum [Member]
Patents And Intellectual Property [Member]
Maximum [Member]
Amortization expense
Amortization of long-lived asset on straight line basis
Derivative Instrument [Axis]
Equity Incentive Plan 2015 [Member]
Stock options expired
Stock options grant date
Stock options cancelled
Stock options cancellation date
Stock options cancelled grant price
Equity Incentive Plan 2015 One [Member]
Equity Incentive Plan 2015 Two [Member]
Equity Incentive Plan 2015 Three [Member]
Equity Incentive Plan 2015 Four [Member]
Equity Incentive Plan 2015 Five [Member]
Equity Incentive Plan 2015 Six [Member]
Equity Incentive Plan 2015 Seven [Member]
Equity Incentive Plan 2015 Eight [Member]
Equity Incentive Plan 2015 [Member]
[Equity Incentive Plan 2015 [Member]]
Incentive Plan
Equity Incentive RSU
Vest date
Shares Issued
Shares Withheld for Taxes
Award Type [Axis]
Restricted Stock Units (RSUs) [Member]
Equity Incentive Plan 2024 One [Member]
Equity Incentive Plan 2024 [Member]
Equity Incentive Plan 2024 Two [Member]
Vest date
Equity Incentive RSU
Shares Issued
Shares Withheld for Taxes
Incentive Plan
[Incentive Plan]
Related and Nonrelated Parties [Axis]
Securities Purchase Agreement [Member]
Lind Global Asset Management XII LLC [Member]
2025 ATM Sales Agreement [Member]
2026 Lind Note [Member]
Shares Issued in Repayment of Convertible Notes
June 2026 Confidentially Marketed Public Offering [Member]
September 2025 Private Placement [Member]
Underwriting Agreement [Member]
Directors And Officers [Member]
Common stock, shares issued
Common Stock, shares, outstanding
Agreement of several purchases offering, description
Common stock aggregate offering price amount
Description of aggregate offering price
Sales commissions and fees
Sales commissions and fees, shares
Sale of shares of common stock
Sale of shares of common stock, shares
Common stock price per share
Common stock, shares authorized
Warrants issued to purchase common shares
Common stock per share
Number of installments
Conversion price
Repayment obligations
Monthly installments
Installment description
Aggregate share
Repayment conversion description
Offering price
Aggregate fair value
Loss on extinguishment of debt
Warrants exercise price
Placement fees
Warrants fully exercised on cash basis
Warrants expiry date
Funding received
Principal amount
Commitment fee
Number of warrants issued
Purchased shares of common stock
Proceed from issuance and sale of shares and warrants
Common stock issued for cash, net of issuance costs, shares
Offering expenses
Net proceeds
Initial shares of common stock
Offering expenses
[Offering expenses]
Combined offering price
Exercise price per share
Pre-funded warrants
Purchase option warrants
Purchase option Shares
Purchase price per share
Purchase to additional shares of options
Exercise prices
Purchase to additional shares of common stock
Issued warrants to purchase shares of common stock
Common stock offering price
Fees and expenses
Warrants [Member]
Number of warrants Outstanding beginning balance
[Class of Warrant or Right, Outstanding]
Number of warrants granted
Number of warrants Expired/Cancelled
Number of warrants outstanding ending balance
Number of Warrants Exercisable
Weighted Average Exercise Price, beginning
[Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price]
Weighted Average Exercise Price Granted
Weighted Average Exercise Price Expired/Cancelled
Weighted Average Exercise Price, ending
Weighted Average Exercise Price exercisable
Series A and Series B Common Stock Warrants [Member]
Number of warrants granted
Number of warrants Exercised
Number of warrants Expired/Cancelled
Number of Warrants Exercisable
Weighted Average Exercise Price Granted
Weighted Average Exercise Price Exercised
Weighted Average Exercise Price Expired/Cancelled
Weighted Average Exercise Price exercisable
Warrants Nine [Member]
Warrants Ten [Member]
Warrants Eleven [Member]
Warrants Twelve [Member]
Warrants Thirteen [Member]
Warrants Fourteen [Member]
Warrants Fifteen [Member]
Warrants Six [Member]
Warrants Seven [Member]
Warrants Eight [Member]
Warrants Sixteen [Member]
Warrant One [Member]
Warrant Two [Member]
Warrant Three [Member]
Warrants Four [Member]
Warrants Five [Member]
Weighted Average Remaining Contractual Life (Years)
Number Exercisable
Number Outstanding
Proceeds to Company if Exercised
Exercise Price
Financial Instrument [Axis]
Option [Member]
Number of options outstanding beginning balance
[Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Number of Shares]
Number of option outstanding ending balance
Number of option Exercisable
Weighted Average Exercise Price Expired/Cancelled
Weighted Average Exercise Price exercisable balance
Options One [Member]
Option Two [Member]
Option Three [Member]
Option Four [Member]
Option Five [Member]
Total Option [Member]
Option Six [Member]
Option Seven [Member]
Number Outstanding, shares
Number Exercisable, shares
Exercise Price
Weighted Average Remaining Contractual Life (years)
Proceeds to Company if Exercised
[Proceeds from Stock Options Exercised]
2015 Plan
Equity Incentive Plan [Member]
Options
Grant date
Options cancelled
Grant price
Cancellation date
2015 Plan
Restricted Stock Units (RSUs) [Member]
Number of RSUs Outstanding Begining Balance
Vested/Settled
[Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested, Number of Shares]
Cancelled / Forfeited
[Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested Options Forfeited, Number of Shares]
Number of RSUs Outstanding Ending Balance
Weighted Average Exercise Price Granted
Weighted Average Exercise Price Vested/Settled
Restricted Stock Units (RSUs) One [Member]
Restricted Stock Units (RSUs) Two [Member]
Restricted Stock Units (RSUs) Three [Member]
Restricted Stock Units (RSUs) Four [Member]
Restricted Stock Units (RSUs) Five [Member]
Restricted Stock Units (RSUs) Six [Member]
Restricted Stock Units (RSUs) Seven [Member]
Restricted Stock Units (RSUs) Eight [Member]
Number Outstanding, shares
Exercise Price
Weighted Average Remaining Contractual Life (years)
Equity Incentive Plan Six [Member]
Equity Incentive Plan Seven [Member]
Equity Incentive Plan Eight [Member]
Equity Incentive Plan One [Member]
Equity Incentive Plan Two [Member]
Equity Incentive Plan Three [Member]
Equity Incentive Plan Four [Member]
Equity Incentive Plan Five [Member]
Equity Incentive RSU
[Equity Incentive RSU]
Vest date
Incentive RSU Issued
RSUs Held for Taxes
Incentive RSU Issued
RSUs Cancelled
Cancellation date
2024 Plan
Number of RSUs Exercisable
Weighted Average Exercise Price Vested/Settled
Weighted Average Exercise Price Exercisable
Restricted Stock Units (RSUs) One [Member]
Restricted Stock Units (RSUs) Two [Member]
Restricted Stock Units (RSUs) Three [Member]
Restricted Stock Units (RSUs) Four [Member]
Restricted Stock Units (RSUs) Five [Member]
Weighted Average Remaining Contractual Life (years)
2024 Plan
Equity Incentive Plan One [Member]
Equity Incentive Plan [Member]
Grant Date
Vesting period
RSU Expense
Equity Incentive Plan Two [Member]
RSU Vested
Vest date
[Vest date]
Incentive RSU Issued
Restricted Stock Units (RSUs) Six [Member]
Vesting Date
[Vesting Date]
Incentive RSU Issued
[Incentive RSU Issued]
RSUs Cancelled
[RSUs Cancelled]
Cancellation date
Warrants Granted [Member]
Cancelled warrants
Maturity term
Common stock, exercise features
Exercise price adjustments description
Warrants incremental value
Weighted average contractual life
Stock option purchase
Shares of common stock were authorized for issuance
Stock-based compensation expense
Common stock, shares issued
Warrants to purchase
Exercise price of warrants or rights
Proceeds from issuance of warrants
Unrecognized compensation cost related to non-vested RSU
Common stock shares reserved for future issuance
Offering price
[Offering price]
Longterm Debt Type Axis
Finance Lease Obligations [Member]
2026 - Remaining
[Finance Lease, Liability, to be Paid, Remainder of Fiscal Year]
2027
[Finance Lease, Liability, to be Paid, Year One]
2028
[Finance Lease, Liability, to be Paid, Year Two]
2029
[Finance Lease, Liability, to be Paid, Year Three]
2030
[Finance Lease, Liability, to be Paid, Year Four]
Greater than 5 years
[Greater than 5 years]
Total
[Finance Lease, Liability, to be Paid]
Less: Amount representing interest
[Finance Lease, Liability, Undiscounted Excess Amount]
Present value of minimum lease payments
Operating Lease Right-of-Use Liabilities [Member]
Operating right-of-use assets
Operating lease liabilities, current portion
Operating lease liabilities, long term
Total operating lease liabilities
Weighted average remaining lease (months)
Weighted average discount rate
Other Commitments Axis
Operating Lease Right of Use Obligations [Member]
2026 - Remaining
[Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year]
2027
[Lessee, Operating Lease, Liability, to be Paid, Year One]
2028
[Lessee, Operating Lease, Liability, to be Paid, Year Two]
2029
[Lessee, Operating Lease, Liability, to be Paid, Year Three]
Total Operating Lease
Less: imputed interest
[Lessee, Operating Lease, Liability, Undiscounted Excess Amount]
Total Operating Lease Liabilities
Short Term Office Leases [Member]
2026 - Remaining
2027
Total Operating Lease Liabilities
Grants Repayable [Member]
2026 - Remaining
[2026 - Remaining]
2027
[2027]
2028
[2028]
2029
[2029]
2030
[2030]
Greater than 5 years
[Greater than 5 years 1]
Total Grants Repayable
2026 - Remaining
[Long-Term Debt, Maturity, Remainder of Fiscal Year]
2027
[Long-Term Debt, Maturity, Year One]
2028
[Long-Term Debt, Maturity, Year Two]
2029
[Long-Term Debt, Maturity, Year Three]
2030
[Long-Term Debt, Maturity, Year Four]
Greater than 5 years
[Long-Term Debt, Maturity, Year Four and Five]
Total
[Long-Term Debt, Maturity, after Year Five]
Less: Amount representing interest
[Less: Amount representing interest]
Total Long-Term Debt
Title and Position [Axis]
National University of Taiwan
MD Anderson Cancer Center
Guys and St Thomas
Xenetic Biosciences
Gustave Roussy
2026
2026
[2026]
National University of Taiwan Second
Collaborative agreement obligations
Short-Term Debt, Type [Axis]
Convertible Notes Payable 2025 Lind note [Member]
Convertible Notes Payable 2026 Lind note [Member]
Convertible Notes Payable 2025 and 2026 Lind note [Member]
2026 - Remaining
[2026 - Remaining 1]
2027
[2027 1]
Total Payments
Debt Carrying Value
Debt discount
[Debt Instrument, Unamortized Discount]
Current portion of convertible note payable, net
Debt Carrying Value, current
Debt discount, current
Convertible note payable, net of current portion
Debt Carrying Value, current
Outstanding Award 1
Restricted stock option
[Restricted stock option]
Restricted stock option
Outstanding Award 3
Outstanding Award 2
Total
[Total]
Outstanding award
Vesting period
[Vesting period]
Amortised of outstanding award 2026
Amortised of outstanding award 2025
Amortised of outstanding award 2024
Amortised of outstanding award 2023
Un-amortised of outstanding award
Outstanding Award 1
Restricted Stock Options Vested [Member]
Outstanding Award 2
Outstanding Award 3
Vesting period
Amortised of outstanding award 2026
Outstanding award
Amortised of outstanding award 2025
[Amortised of outstanding award 2025]
Un-amortised of outstanding award
Cancelled of outstanding award
Debt Instrument [Axis]
Statement Geographical Axis
Gustave Roussy [Member]
Restricted Stock Units [Member] | One
SA Namur Invest Preface [Member]
Loan Agreement [Member]
Wallonie Entreprendre [Member]
Notes Payable [Member]
Managing Director's Agreement [Member]
VolitionRx [Member]
In 2016 [Member]
Long-term Debt [Member]
Restricted Stock Units [Member] | Two
University of Taiwan [Member]
In 2018 [Member]
Clinical Study Research Agreement [Member]
Univercity Of Texas MD [Member]
Two Thousand Twenty Two [Member]
Guy's and St Thomas' NHS Foundation Trust [Member]
August Two Thousand Twenty Three [Member]
Xenetic Biosciences Inc and CLS Therapeutics [Member]
July Thirty One Thousand Twenty Three [Member]
Convertible Notes Payable [Member]
Board of Directors [Member]
National University of Taiwan Second [Member]
October Two Thousand Twenty Four [Member]
Restricted Stock Units [Member]
Grant repyable
Monthly payment
Monthly payments
Convertible promissory note
Warrant for purchase common stock
Stock upon repayment or conversion description
Initial fair value description
Initial fair value
Original issue discount
Debt issuance costs
Debt discount net
Number of RSUs granted
RSUs cancelled during period
Maximum borrowing capacity
Long-term debt, interest rate
Long-term debt, maturity date
Long-term debt
Loan principal balance payable
Proceeds from issuance of debt
Warrant issued to purchase common stock
Long-term debt payable
Debt instrument carrying amount
Increase in outstanding principal
Aggregate increase in outstanding principal
Additional cost of company
Due to related party
Outstanding principal balance
Interest rate
Royalty payment
Royality percentage
Royalties payable
Cash paid for operating lease, liability
Operating lease expense
Short term lease costs
Share-based compensation arrangement by share-based payment award expense
Unrecognized compensation expense
RSU vested in 2026
RSU vested in 2027
RSU vested in 2028
Payment to related party
Collaborative obligations amount due
Lease agreement expire period
Subsequent Event Type Axis
Subsequent Event [Member]
Fourth Amendment
Top [Member]
2025 ATM Sales Agreement [Member]
[2025 ATM Sales Agreement [Member]]
Bottom [Member]
Issuance of shares of common stock
RSUs cancellations
Common stock shares, conversion of convertible securities
Common stock shares, conversion of convertible securities repayment
Sold shares of common stock, shares
Sold shares of common stock, amount
Common stock, shares par value